Showing results (141-150 of 202) with videos related to
Sort By:
Pageof 21
Open Forum Infectious Diseases|April 18, 2015
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group ProtocolsCarrie B Moore, Anurag Verma, Sarah Pendergrass, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral TreatmentGrant B Ellsworth, Leah A Burke, Martin T Wells, et al.The Journal of Infectious Diseases|October 31, 2009
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211Zhaohui Su, Roy M Gulick, Amy Krambrink, et al.Journal of Virology|November 5, 2010
Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive diseaseJulian Schulze Zur Wiesch, Adriana Thomssen, Philip Hartjen, et al.AIDS (London, England)|November 14, 2008
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?, Michael J Mugavero, Margaret May, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2009
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppressionDavid M Moore, Ross Harris, Viviane Lima, et al.Plos One|July 24, 2020
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 diseaseMichael J Satlin, Parag Goyal, Reed Magleby, et al.Plos One|December 27, 2018
No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305Shashi N Kapadia, Chunyuan Wu, Kenneth H Mayer, et al.The Journal of Infectious Diseases|January 28, 2010
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failureRoger Paredes, Christina M Lalama, Heather J Ribaudo, et al.AIDS Research and Human Retroviruses|February 20, 2018
Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear CellsDominique B Figueroa, Erin P Madeen, Joseph Tillotson, et al.Pageof 21